Logical transformation of genome-scale metabolic models for gene level applications and analysis

Bioinformatics

Volumn 31, Issue 14, 2015, Pages 2324-2331

  Zhang, Cheng ^a,b   Ji, Boyang ^b   Mardinoglu, Adil ^b   Nielsen, Jens ^b   Hua, Qiang ^a,c  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c SHANGHAI COLLABORATIVE INNOVATION CENTER FOR BIOMANUFACTURING TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN;

BACTERIAL GENOME; BIOLOGICAL MODEL; BIOLOGY; COMPUTER LANGUAGE; COMPUTER SIMULATION; FUNGAL GENOME; HUMAN; HUMAN GENOME; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PROCEDURES; SYSTEMS BIOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; ESCHERICHIA COLI PROTEINS; GENOME, BACTERIAL; GENOME, FUNGAL; GENOME, HUMAN; HUMANS; LIVER NEOPLASMS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; PROGRAMMING LANGUAGES; SACCHAROMYCES CEREVISIAE PROTEINS; SYSTEMS BIOLOGY;

EID: 84941656865     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv134     Document Type: Article

References (51)

1. Agren, R. et al. (2013) The RAVEN toolbox and its use for generating a genomescale model for Penicillium chrysogenum. PLoS Comput. Biol., 9, e1002980.
2. Agren, R. et al. (2014) Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol., 10, 721.
3. Aung, H. W. et al. (2013) Revising the representation of fatty acid, glycerolipid, and glycerophospholipid metabolism in the consensus model of yeast metabolism. Ind. biotechnol., 9, 215-228.
4. Barabasi, A. L. et al. (2011) Network medicine: A network-based approach to human disease. Nat. Rev. Genet., 12, 56-68.
5. Becker, S. A. and Palsson, B. O. (2008) Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol., 4, e1000082.
6. Bernards, R. et al. (2006) shRNA libraries and their use in cancer genetics. Nat. Methods, 3, 701-706.
7. Brochado, A. R. et al. (2010) Improved vanillin production in baker's yeast through in silico design. Microb. Cell Fact., 9, 84.
8. Burgard, A. P. et al. (2003) Optknock: A bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol. Bioeng., 84, 647-657.
9. Chandrasekaran, S. and Price, N. D. (2010) Probabilistic integrative modeling of genome-scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA, 107, 17845-17850.
10. Cho, S. W. et al. (2013) Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol., 31, 230-232.
11. Choi, H. S. et al. (2010) In silico identification of gene amplification targets for improvement of lycopene production. Appl. Environ. Microbiol., 76, 3097-3105.
12. Chong, S. K. et al. (2014) A hybrid of ant colony optimization and minimization of metabolic adjustment to improve the production of succinic acid in Escherichia coli. Comput. Biol. Med., 49, 74-82.
13. Choon, Y. W. et al. (2014) A hybrid of bees algorithm and flux balance analysis with OptKnock as a platform for in silico optimization of microbial strains. Bioprocess Biosyst. Eng., 37, 521-532.
14. Egen, D. and Lun, D. S. (2012) Truncated branch and bound achieves efficient constraint-based genetic design. Bioinformatics, 28, 1619-1623.
15. Feist, A. M. and Palsson, B. O. (2010) The biomass objective function. Curr. Opin. Microbiol., 13, 344-349.
16. Feist, A. M. et al. (2007) A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol. Syst. Biol., 3, 121.
17. Flavin, R. et al. (2010) Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol., 6, 551-562.
18. Fowler, Z. L. et al. (2009) Increased malonyl coenzyme A biosynthesis by tuning the Escherichia coli metabolic network and its application to flavanone production. Appl. Environ. Microbiol., 75, 5831-5839.
19. Hamilton, J. J. et al. (2013) Quantitative assessment of thermodynamic constraints on the solution space of genome-scale metabolic models. Biophys. J., 105, 512-522.
20. Harrison, R. et al. (2007) Plasticity of genetic interactions in metabolic networks of yeast. Proc. National Acad. Sci. USA, 104, 2307-2312.
21. Hoppe, A. et al. (2007) Including metabolite concentrations into flux balance analysis: Thermodynamic realizability as a constraint on flux distributions in metabolic networks. BMC Syst. Biol., 1, 23.
22. Jerby-Arnon, L. et al. (2014) Predicting cancer-specific vulnerability via datadriven detection of synthetic lethality. Cell, 158, 1199-1209.
23. Ji, B. and Nielsen, J. (2015) New insight into the gut microbiome through metagenomics. Adv. Genomics Genet., 5, 77-91.
24. Kim, H. J. et al. (2013) Genome-wide analysis of redox reactions reveals metabolic engineering targets for D-lactate overproduction in Escherichia coli. Metab. Eng., 18, 44-52.
25. Kim, J. and Reed, J. L. (2010) OptORF: optimal metabolic and regulatory perturbations for metabolic engineering of microbial strains. BMC Syst. Biol., 4, 53.
26. Lun, D. S. et al. (2009) Large-scale identification of genetic design strategies using local search. Mol. Syst. Biol., 5, 296.
27. Mardinoglu, A. et al. (2013a) Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol., 9, 649.
28. Mardinoglu, A. et al. (2013b) Genome-scale modeling of human metabolism - A systems biology approach. Biotechnol. J., 8, 985-996.
29. Mardinoglu, A. and Nielsen, J. (2012) Systems medicine and metabolic modelling. J. Intern. Med., 271, 142-154.
30. Mardinoglu, A. and Nielsen, J. (2015) New paradigms for metabolic modeling of human cells. Curr. Opin. Biotechnol., 34C, 91-97.
31. Mardinoglu, A. et al. (2014) Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun., 5, 3083.
32. Matsuda, F. et al. (2011) Engineering strategy of yeast metabolism for higher alcohol production, Microbial Cell Factories, 10, 70.
33. Nam, H. et al. (2014) A systems approach to predict oncometabolites via context-specific genome-scale metabolic networks. PLoS Comput. Biol., 10, e1003837.
34. Nocon, J. et al. (2014) Model based engineering of Pichia pastoris central metabolism enhances recombinant protein production. Metab. Eng., 24, 129-138.
35. Orth, J. D. et al. (2010) What is flux balance analysis? Nat. Biotechnol., 28, 245-248.
36. Patil, K. R. et al. (2005) Evolutionary programming as a platform for in silico metabolic engineering, BMC Bioinform., 6, 308.
37. Pharkya, P. and Maranas, C. D. (2006) An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. Metab. Eng., 8, 1-13.
38. Pratapa, A. et al. (2014) Fast-SL an efficient algorithm to identify synthetic lethal reaction sets in metabolic networks. arXiv: 1406. 6557v2 [q-bio. MN]. Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600 036, INDIA; Department of Computer Science and Engineering, Indian Institute of Technology Madras.
39. Ranganathan, S. and Maranas, C. D. (2010) Microbial 1-butanol production: Identification of non-native production routes and in silico engineering interventions. Biotechnol. J., 5, 716-725.
40. Ranganathan, S. et al. (2010) OptForce: An optimization procedure for identifying all genetic manipulations leading to targeted overproductions. PLoS Comput. Biol., 6, e1000744.
41. Ranganathan, S. et al. (2012) An integrated computational and experimental study for overproducing fatty acids in Escherichia coli. Metab. Eng., 14, 687-704.
42. Reed, J. et al. (2003) An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol., 4, R54.
43. Reznik, E. et al. (2013) Flux imbalance analysis and the sensitivity of cellular growth to changes in metabolite pools. PLoS Comput. Biol., 9, e1003195.
44. Ryan, C. J. et al. (2014) DAISY: picking synthetic lethals from cancer genomes. Cancer Cell, 26, 306-308.
45. Schellenberger, J. et al. (2011) Quantitative prediction of cellular metabolism with constraint-based models: The COBRA Toolbox v2. 0. Nat. Protoc., 6, 1290-1307.
46. Segre, D. et al. (2005) Modular epistasis in yeast metabolism. Nat. Genet., 37, 77-83.
47. Suthers, P. F. et al. (2009) Genome-scale gene/reaction essentiality and synthetic lethality analysis, Mol. Syst. Biol., 5, 301.
48. Tepper, N. et al. (2013) Steady-state metabolite concentrations reflect a balance between maximizing enzyme efficiency and minimizing total metabolite load. PloS One, 8, e75370.
49. Xu, P. et al. (2011) Genome-scale metabolic network modeling results in minimal interventions that cooperatively force carbon flux towards malonyl-CoA. Metab. Eng., 13, 578-587.
50. Yizhak, K. et al. (2014) A computational study of the Warburg effect identifiesmetabolic targets inhibiting cancermigration. Mol. Syst. Biol., 10, 744.
51. Zhang, F. and Du, G. (2012) Dysregulated lipid metabolism in cancer. World J. Biol. Chem., 3, 167-174.